Details of Disease

General Information of Disease (ID: DIS184KT)

• Disease Name: Skin inflammation
• Disease Class: EF20: Acquired cutaneous blood vessel malformation
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DIS184KT: Skin inflammation
• ICD Code:
  ICD-11: ICD-11: EF20.Y
  ICD-9: ICD-9: 709.8
  Expand ICD-9: 709.8
• Disease Identifiers:
  MONDO ID: MONDO_0021166
  UMLS CUI: C1290884
  MedGen ID: 452939
  SNOMED CT ID: 128139000

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Dihydroxyaluminium	DM8YXKW	Approved	Small molecular drug	[1]

This Disease is Treated as An Indication in 6 Patented Agent(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Benzothiazine-carboxamide compound 1	DMJ51VZ	Patented	Small molecular drug	[2]
Benzothiazine-carboxamide compound 2	DMMP2RT	Patented	Small molecular drug	[2]
Benzothiazine-carboxamide compound 3	DMI31OD	Patented	Small molecular drug	[2]
Benzothiazine-carboxamide compound 4	DMSR918	Patented	Small molecular drug	[2]
Benzothiazine-carboxamide compound 5	DMM7N5E	Patented	Small molecular drug	[2]
Benzothiazine-carboxamide compound 6	DMW94IQ	Patented	Small molecular drug	[2]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Drug information of Dihydroxyaluminium, Health Canada, 2007.
• [2] Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).Expert Opin Ther Pat. 2016;26(4):471-83.